Association of Clinical Research Organizations

Tweet this page
<
2016
2017
2018
2019
2020
2022
2023
>
Registration as it was on 27 Oct 2023
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

100,000€ - 199,999€

Financial year: Nov 2022 - Oct 2023

Lobbyists (Full time equivalent)

0.5 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Association of Clinical Research Organizations   (ACRO)

    EU Transparency Register

    150920420956-26 First registered on 07 Mar 2016

    Goals / Remit

    ACRO and its members advocate on a global basis for safe, ethical, high-quality medical research so patients can benefit from the development of new treatments and therapies. Our members are dedicated to helping their clients bring efficiency, innovation and value to the clinical research process.

    The Association of Clinical Research Organizations (ACRO) represents both (1) the world's leading, global clinical research organizations (CROs) and (2) global technology companies. Our member companies provide a wide range of specialized services across the entire spectrum of development for new drugs, biologics and medical devices – from discovery, pre-clinical, proof of concept and first-in-man studies through post-approval and pharmacovigilance research. ACRO advances clinical outsourcing to improve the quality, efficiency and safety of biomedical research.

    Main EU files targeted

    As the voice of leading global CROs (clinical research organizations) and global technology companies, ACRO monitors and analyzes initiatives, policies, legislation, and regulation impacting clinical research and drug development. In addition to participating in numerous public consultations and numerous industry stakeholder workshops on multiple topics within the clinical research enterprise, ACRO and its members are deeply engaged in addressing the requirements of the EU Clinical Trial Regulation and the General Data Protection Regulation. ACRO also follows initiatives and policies on innovation in clinical research and trial design -- in addition to the increasing digitization of clinical trials (e.g., decentralized clinical trials; electronic consent; electronic signatures; and emerging topics such as the potential and promise of artificial intelligence and machine learning to assist in drug development).

    Address

    Head Office
    601 New Jersey Ave NW Suite 350
    Washington 20001
    UNITED STATES
    EU Office
    601 New Jersey Ave NW Suite 350
    Washington 20001
    UNITED STATES

    Website

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    25%2

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    The ACRO Senior Vice President of Global Regulatory Policy is 1/3 (one third) of an FTE.

    The ACRO Regulatory Consultant is 1/8 (one eighth) of an FTE.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Trade and business associations

  • Networking

    Affiliation

    None declared

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Nov 2022 - Oct 2023

    Lobbying costs for closed financial year

    100,000€ - 199,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    100,000€ - 199,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    ACRO (www.acrohealth.org) maintains a robust communications/public relations program with an emphasis on European Union and United States legislative, regulatory and business issues effecting clinical trials and life sciences. In addition to traditional media, ACRO is active on social media through Facebook, LinkedIn, YouTube (ACROHealth Channel), and other additional social media channels.

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard